Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines.

Goldstein J, Hoffman T, Frasch C, Lizzio EF, Beining PR, Hochstein D, Lee YL, Angus RD, Golding B.

Infect Immun. 1992 Apr;60(4):1385-9.

2.

Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependency, and syncytia inhibition.

Golding B, Golding H, Preston S, Hernandez D, Beining PR, Manischewitz J, Harvath L, Blackburn R, Lizzio E, Hoffman T.

AIDS Res Hum Retroviruses. 1991 May;7(5):435-46.

PMID:
1678617
3.

Immunogenicity of lipopolysaccharide derived from Brucella abortus: potential as a carrier in development of vaccines for AIDS.

Goldstein J, Hernandez D, Frasch C, Beining PR, Betts M, Hoffman T, Golding B.

Adv Exp Med Biol. 1991;303:227-33.

PMID:
1805568
6.
7.
8.

Characterization of the lipids of mesosomal vesicles and plasma membranes from Staphylococcus aureus.

Beining PR, Huff E, Prescott B, Theodore TS.

J Bacteriol. 1975 Jan;121(1):137-43.

9.

Alteration of permeability of protoplasts of Bacillus megaterium by bacitracin and selected metallic ions.

Beining PR, Pinsley CL, Weinberg ED.

Antimicrob Agents Chemother (Bethesda). 1966;6:308-11. No abstract available.

PMID:
4964456
10.

Supplemental Content

Loading ...
Support Center